D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Amazon
AMZN
|
+$490M |
| 2 |
Microsoft
MSFT
|
+$461M |
| 3 |
Estee Lauder
EL
|
+$422M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$239M |
| 5 |
Nike
NKE
|
+$234M |
Top Sells
| 1 |
Walmart
WMT
|
+$585M |
| 2 |
Tesla
TSLA
|
+$470M |
| 3 |
NVIDIA
NVDA
|
+$431M |
| 4 |
Eli Lilly
LLY
|
+$360M |
| 5 |
T-Mobile US
TMUS
|
+$299M |
Sector Composition
| 1 | Technology | 26.44% |
| 2 | Consumer Discretionary | 14.71% |
| 3 | Healthcare | 12.37% |
| 4 | Financials | 8.93% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HPP
651
Hudson Pacific Properties
HPP
$1.1B
| $12M | 0.01% |
1,802,588
-613,470
| -25% | -$4.08M |
|
652
Pebblebrook Hotel Trust
PEB
$1.39B
| $12M | 0.01% |
881,967
+39,571
| +5% | +$538K |
|
653
Rogers Corp
ROG
$1.45B
| $12M | 0.01% |
91,005
+4,819
| +6% | +$634K |
|
654
Trane Technologies
TT
$93.9B
| $11.9M | 0.01% |
58,861
-60,458
| -51% | -$12.3M |
|
655
Lantheus
LNTH
$3.59B
| $11.9M | 0.01% |
171,356
-386,997
| -69% | -$26.9M |
|
|
CBAY
656
DELISTED
Cymabay Therapeutics
CBAY
| $11.9M | 0.01% |
798,009
+105,608
| +15% | +$1.57M |
|
657
Warrior Met Coal
HCC
$3.14B
| $11.9M | 0.01% |
232,188
-304,339
| -57% | -$15.5M |
|
658
Principal Financial Group
PFG
$18.1B
| $11.8M | 0.01% |
164,367
+18,697
| +13% | +$1.35M |
|
659
Arch Capital
ACGL
$34B
| $11.8M | 0.01% |
148,598
-156,639
| -51% | -$12.5M |
|
660
Cognex
CGNX
$7.51B
| $11.8M | 0.01% |
278,915
+150,306
| +117% | +$6.38M |
|
661
Enbridge
ENB
$106B
| $11.8M | 0.01% |
355,030
+110,200
| +45% | +$3.66M |
|
662
Sprinklr
CXM
$1.91B
| $11.8M | 0.01% |
851,084
-89,314
| -9% | -$1.24M |
|
663
IDEAYA Biosciences
IDYA
$2.2B
| $11.8M | 0.01% |
436,358
+223,143
| +105% | +$6.02M |
|
664
RH
RH
$4.33B
| $11.8M | 0.01% |
44,529
-268,089
| -86% | -$70.9M |
|
665
Cigna
CI
$81.3B
| $11.8M | 0.01% |
41,146
-250,617
| -86% | -$71.7M |
|
666
Vicor
VICR
$2.29B
| $11.7M | 0.01% |
198,313
+116,171
| +141% | +$6.84M |
|
667
Box
BOX
$4.74B
| $11.7M | 0.01% |
481,716
-146,249
| -23% | -$3.54M |
|
668
BlackBerry
BB
$2.28B
| $11.7M | 0.01% |
2,473,472
-1,181,108
| -32% | -$5.56M |
|
669
MYR Group
MYRG
$2.78B
| $11.6M | 0.01% |
86,411
-4,852
| -5% | -$654K |
|
670
BILL Holdings
BILL
$5.31B
| $11.6M | 0.01% |
107,176
+92,904
| +651% | +$10.1M |
|
671
British American Tobacco
BTI
$124B
| $11.6M | 0.01% |
370,179
-884,674
| -71% | -$27.8M |
|
|
JBTM
672
JBT Marel Corporation
JBTM
$7.25B
| $11.6M | 0.01% |
110,425
+40,782
| +59% | +$4.29M |
|
673
Cardlytics
CDLX
$52.7M
| $11.6M | 0.01% |
702,943
-333,690
| -32% | -$5.51M |
|
674
Rambus
RMBS
$9.31B
| $11.6M | 0.01% |
207,310
-412,482
| -67% | -$23M |
|
675
Teekay Tankers
TNK
$1.77B
| $11.6M | 0.01% |
277,485
-108,373
| -28% | -$4.51M |
|